17 August 2026
Australia's CSL reports 2% fall in annual profit

Aug 18 (Reuters) - Australia's CSL on Tuesday posted a 2% fall in annual profit, dragged by declining revenue at its core plasma division. The company, among the world's top flu vaccine makers, ...
About this report
This article contains independently written commentary and community perspective from Downunder Voices.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.
